Benign T cells drive clinical skin inflammation in cutaneous T cell lymphoma
- PMID: 30626755
- PMCID: PMC6485670
- DOI: 10.1172/jci.insight.124233
Benign T cells drive clinical skin inflammation in cutaneous T cell lymphoma
Abstract
Psoralen plus UVA (PUVA) is an effective therapy for mycosis fungoides (MF), the skin-limited variant of cutaneous T cell lymphoma (CTCL). In low-burden patients, PUVA reduced or eradicated malignant T cells and induced clonal expansion of CD8+ T cells associated with malignant T cell depletion. High-burden patients appeared to clinically improve but large numbers of malignant T cells persisted in skin. Clinical improvement was linked to turnover of benign T cell clones but not to malignant T cell reduction. Benign T cells were associated with the Th2-recruiting chemokine CCL18 before therapy and with the Th1-recruiting chemokines CXCL9, CXCL10, and CXCL11 after therapy, suggesting a switch from Th2 to Th1. Inflammation was correlated with OX40L and CD40L gene expression; immunostaining localized these receptors to CCL18-expressing c-Kit+ dendritic cells that clustered together with CD40+OX40+ benign and CD40+CD40L+ malignant T cells, creating a proinflammatory synapse in skin. Our data suggest that visible inflammation in CTCL results from the recruitment and activation of benign T cells by c-Kit+OX40L+CD40L+ dendritic cells and that this activation may provide tumorigenic signals. Targeting c-Kit, OX40, and CD40 signaling may be novel therapeutic avenues for the treatment of MF.
Keywords: Dermatology; Immunology; Lymphomas.
Conflict of interest statement
Figures
Similar articles
-
Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.J Am Acad Dermatol. 2014 Feb;70(2):205.e1-16; quiz 221-2. doi: 10.1016/j.jaad.2013.07.049. J Am Acad Dermatol. 2014. PMID: 24438969 Review.
-
Roles of OX40 and OX40 Ligand in Mycosis Fungoides and Sézary Syndrome.Int J Mol Sci. 2021 Nov 22;22(22):12576. doi: 10.3390/ijms222212576. Int J Mol Sci. 2021. PMID: 34830466 Free PMC article.
-
High-scatter T cells: a reliable biomarker for malignant T cells in cutaneous T-cell lymphoma.Blood. 2011 Feb 10;117(6):1966-76. doi: 10.1182/blood-2010-05-287664. Epub 2010 Dec 9. Blood. 2011. PMID: 21148332 Free PMC article.
-
STAT3/5-Dependent IL9 Overexpression Contributes to Neoplastic Cell Survival in Mycosis Fungoides.Clin Cancer Res. 2016 Jul 1;22(13):3328-39. doi: 10.1158/1078-0432.CCR-15-1784. Epub 2016 Feb 5. Clin Cancer Res. 2016. PMID: 26851186 Free PMC article.
-
Malignant and Benign T Cells Constituting Cutaneous T-Cell Lymphoma.Int J Mol Sci. 2021 Nov 29;22(23):12933. doi: 10.3390/ijms222312933. Int J Mol Sci. 2021. PMID: 34884736 Free PMC article. Review.
Cited by
-
Systemic and skin-limited delayed-type drug hypersensitivity reactions associate with distinct resident and recruited T cell subsets.J Clin Invest. 2024 Jul 23;134(17):e178253. doi: 10.1172/JCI178253. J Clin Invest. 2024. PMID: 39042477 Free PMC article.
-
Role of IL-4 and IL-13 in Cutaneous T Cell Lymphoma.Life (Basel). 2024 Feb 9;14(2):245. doi: 10.3390/life14020245. Life (Basel). 2024. PMID: 38398754 Free PMC article. Review.
-
Immunosequencing applications in cutaneous T-cell lymphoma.Front Immunol. 2023 Dec 21;14:1300061. doi: 10.3389/fimmu.2023.1300061. eCollection 2023. Front Immunol. 2023. PMID: 38213330 Free PMC article. Review.
-
Cathepsin W, T-cell receptor-associated transmembrane adapter 1, lymphotactin and killer cell lectin like receptor K1 are sensitive and specific RNA biomarkers of canine epitheliotropic lymphoma.Front Vet Sci. 2023 Nov 3;10:1225764. doi: 10.3389/fvets.2023.1225764. eCollection 2023. Front Vet Sci. 2023. PMID: 38026637 Free PMC article.
-
Phototherapy Restores Deficient Type I IFN Production and Enhances Antitumor Responses in Mycosis Fungoides.J Invest Dermatol. 2024 Mar;144(3):621-632.e1. doi: 10.1016/j.jid.2023.06.212. Epub 2023 Sep 15. J Invest Dermatol. 2024. PMID: 37716650
References
-
- Kim YH, Liu HL, Mraz-Gernhard S, Varghese A, Hoppe RT. Long-term outcome of 525 patients with mycosis fungoides and Sezary syndrome: clinical prognostic factors and risk for disease progression. Arch Dermatol. 2003;139(7):857–866. - PubMed
-
- Honig B, Morison WL, Karp D. Photochemotherapy beyond psoriasis. J Am Acad Dermatol. 1994;31(5 Pt 1):775–790. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials